PulseExploreJournal ClubTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 8, 2026ImmunologyOpen Access

The Immune Rheostat: A Shared Regulatory Axis Linking Cancer Immune Evasion and Autoimmune Activation

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSivasangari BalakrishnanKMKarthi Muthuswamy

Discussion

Loading...

Member takes

Overview

Review uncovers a shared regulatory axis balancing cancer evasion and autoimmunity across immune disorders, highlighting how coordinated pathway rewiring restores immune homeostasis.

Key Points

  • To establish the 'immune rheostat' framework unifying shared molecular and cellular pathways that drive both cancer immune evasion and autoimmune activation.
  • Synthesized molecular evidence on checkpoint co-signaling, T-cell exhaustion, regulatory T-cell epigenetic stability, and myeloid polarization.
  • Evaluated clinical data from immune checkpoint inhibitor therapies (targeting PD-1 and CTLA-4) to trace the onset of autoimmune-like adverse events.
  • Analyzed an illustrative lupus nephritis model evaluating follicular regulatory and helper T-cell dynamics to demonstrate homeostatic rewiring.
  • Demonstrates that cancer evasion and autoimmune disease represent opposite ends of a shared regulatory continuum rather than separate biological systems.
  • Shows that targeted checkpoint inhibition shifts the rheostat from tumor tolerance toward autoimmunity, precipitating toxicities that mirror spontaneous autoimmune disease.
  • Defines a non-checkpoint-restricted biomarker panel and layer-specific therapeutic strategies to dynamically monitor and tune immune position.

Cite This Study

Balakrishnan et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd75858e84d0ff5b45ea3https://doi.org/10.1111/imm.70198
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autoimmune Disease and Cancer as Disorders of Regulatory Coherence: A Systems-Level Perspective2026
  2. 2Editorial: Cellular and molecular regulators in non-neoplastic immune-mediated diseases2025 · 1 citations
  3. 3Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?2025 · 53 citations
  4. 4Editorial: Repurposing cancer immunotherapies for use in autoimmunity and transplantation2025
  5. 5Restoring Immune Tolerance in Rheumatic Disease2026